These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12570116)

  • 1. Use of anti-inflammatory therapy and asthma mortality in Japan.
    Suissa S; Ernst P
    Eur Respir J; 2003 Jan; 21(1):101-4. PubMed ID: 12570116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asthma mortality in portugal : impact of treatment with inhaled corticosteroids and leukotriene receptor antagonists.
    Nunes de Melo M; Mendes Z; Martins P; Suissa S
    Treat Respir Med; 2006; 5(2):143-7. PubMed ID: 16512694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma.
    Ducharme FM; Hicks GC
    Cochrane Database Syst Rev; 2000; (3):CD002314. PubMed ID: 10908555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children.
    Ng D; Salvio F; Hicks G
    Cochrane Database Syst Rev; 2004; (2):CD002314. PubMed ID: 15106175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children.
    Ducharme FM; Hicks GC
    Cochrane Database Syst Rev; 2002; (3):CD002314. PubMed ID: 12137655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance therapy with anti-inflammatory antiasthmatic drugs: inhaled corticosteroids and leukotriene receptor antagonists.
    Riccioni G; Bucciarelli T; Mancini B; Di Ilio E; Palumbo G; D'Orazio N
    Clin Ter; 2007; 158(4):363-70. PubMed ID: 17953289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of hospitalization in patients with asthma switched from an inhaled corticosteroid to a leukotriene receptor antagonist.
    Stempel DA; Pinto L; Stanford RH
    J Allergy Clin Immunol; 2002 Jul; 110(1):39-41. PubMed ID: 12110816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of leukotriene receptor antagonists to inhaled corticosteroids improved QOL of patients with bronchial asthma surveyed in suburban Tokyo, Japan.
    Ohshima N; Matsui H; Matsui Y; Kawashima M; Shimada M; Higaki N; Shoji S; Wada H; Fujita A; Watanabe H; Yamaguchi N; Matsuoka R; Oki K; Takahashi H; Suzuki M; Yamazaki H; Yoshizawa M; Goto H
    Allergol Int; 2011 Dec; 60(4):473-81. PubMed ID: 21681017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukotriene receptor antagonists versus inhaled steroids in asthma.
    Richardson CR
    J Fam Pract; 1999 Jul; 48(7):495-6. PubMed ID: 10428241
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhaled corticosteroid use and asthma hospitalization rates in Japan.
    Odajima Y; Kuwabara H
    J Int Med Res; 2006; 34(2):208-14. PubMed ID: 16749417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management and treatment of pediatric asthma: update.
    Skoner DP
    Allergy Asthma Proc; 2001; 22(2):71-4. PubMed ID: 11332294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukotriene-receptor antagonists.
    Lipworth BJ
    Lancet; 1999 Jan; 353(9146):57-62. PubMed ID: 10023966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukotriene modifier vs inhaled corticosteroid in mild-to-moderate asthma: clinical and anti-inflammatory effects.
    Perng DW; Huang HY; Lee YC; Perng RP
    Chest; 2004 May; 125(5):1693-9. PubMed ID: 15136378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of theophylline or pranlukast, a cysteinyl leukotriene receptor 1 antagonist, as add-on therapy in uncontrolled asthmatic patients with a medium dose of inhaled corticosteroids.
    Tsuchida T; Matsuse H; Machida I; Kondo Y; Saeki S; Tomari S; Obase Y; Matsuo N; Shimoda T; Kohno S
    Allergy Asthma Proc; 2005; 26(4):287-91. PubMed ID: 16270722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment options for initial maintenance therapy of persistent asthma: a review of inhaled corticosteroids and leukotriene receptor antagonists.
    Creticos PS
    Drugs; 2003; 63 Suppl 2():1-20. PubMed ID: 14984077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should antileukotriene therapies be used instead of inhaled corticosteroids in asthma? Yes.
    Drazen JM; Israel E
    Am J Respir Crit Care Med; 1998 Dec; 158(6):1697-8. PubMed ID: 9847254
    [No Abstract]   [Full Text] [Related]  

  • 17. Should antileukotriene therapies be used instead of inhaled corticosteroids in asthma? No.
    Wenzel SE
    Am J Respir Crit Care Med; 1998 Dec; 158(6):1699-701. PubMed ID: 9847255
    [No Abstract]   [Full Text] [Related]  

  • 18. Asthma: resource use and costs for inhaled corticosteroid vs leukotriene modifier treatment--a meta-analysis.
    Halpern MT; Khan ZM; Stanford RH; Spayde KM; Golubiewski M
    J Fam Pract; 2003 May; 52(5):382-9. PubMed ID: 12737772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled corticosteroids versus leukotriene antagonists as first-line therapy for asthma: a systematic review of current evidence.
    Ducharme FM
    Treat Respir Med; 2004; 3(6):399-405. PubMed ID: 15658885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial.
    Robinson DS; Campbell D; Barnes PJ
    Lancet; 2001 Jun; 357(9273):2007-11. PubMed ID: 11438132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.